Neutralizing antibody to vesicular stomatitis virus (HTLV-I) pseudotype in infants born to seropositive mothers. 1993

Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
Department of Medicine, Kochi Medical School.

Breast feeding is the major route of mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I). Our experiments with rabbits have shown that passive immunization is capable of blocking cell-to-cell infection of HTLV-I by blood transfusion or breast feeding. In this study, sera were collected serially from 3 infants born to seropositive mothers and were tested for the presence of neutralizing antibody to vesicular stomatitis virus (HTLV-I) pseudotype as well as antibodies to viral structural proteins. There was a good correlation between neutralizing and viral antibody titers, both of which were detectable until 3-6 months after birth. Whether maternally transmitted neutralizing antibody is protective against perinatal infection of HTLV-I remains to be studied.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012698 Serologic Tests Diagnostic procedures involving immunoglobulin reactions. Serodiagnosis,Serologic Test,Serological Tests,Test, Serologic,Tests, Serologic,Serodiagnoses,Serological Test,Test, Serological,Tests, Serological
D014721 Vesicular stomatitis Indiana virus The type species of VESICULOVIRUS causing a disease symptomatically similar to FOOT-AND-MOUTH DISEASE in cattle, horses, and pigs. It may be transmitted to other species including humans, where it causes influenza-like symptoms. Vesicular stomatitis-Indiana virus
D014758 Viral Core Proteins Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the NUCLEOCAPSID. Core Proteins, Viral,Major Core Protein,Major Core Proteins, Viral,Adenovirus Core Protein VII,Core Protein V,Core Protein lambda 2,Influenza Virus Core Proteins,Major Core Protein lambda 1,Major Core Protein lambda-1,Major Core Protein sigma 2,Major Core Protein sigma-2,OVP 19,Oncornaviral Protein P19,P30 Core Proteins,Viral Protein P19,Virus Core Proteins,Core Protein, Major,Core Proteins, P30,Core Proteins, Virus,Protein P19, Oncornaviral,Protein P19, Viral,Protein, Major Core,Proteins, P30 Core,Proteins, Viral Core,Proteins, Virus Core
D015481 HTLV-I Antibodies Antibodies reactive with the HTLV-I ANTIGENS. ATLV Antibodies,Human T-Cell Leukemia Virus I Antibodies,Leukemia-Lymphoma Virus I Antibodies, Human T-Cell,T-Cell Leukemia Virus I Antibodies, Adult,T-Cell Leukemia Virus I Antibodies, Human,HTLV I Antibodies,Human T Cell Leukemia Virus I Antibodies,Leukemia Lymphoma Virus I Antibodies, Human T Cell,T Cell Leukemia Virus I Antibodies, Adult,T Cell Leukemia Virus I Antibodies, Human,Antibodies, ATLV,Antibodies, HTLV I,Antibodies, HTLV-I,I Antibodies, HTLV

Related Publications

Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
March 1990, Nihon Sanka Fujinka Gakkai zasshi,
Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
September 2016, Viruses,
Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
September 1989, Japanese journal of cancer research : Gann,
Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
December 2006, Journal of medical virology,
Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
January 1990, Soins. Gynecologie, obstetrique, puericulture, pediatrie,
Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
June 2015, Acta virologica,
Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
July 2014, Journal of virology,
Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
July 1989, Journal of medical virology,
Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
July 1986, Acta virologica,
Y Iwahara, and T Sawada, and H Taguchi, and H Hoshino, and M Umemoto, and H Take, and S Foung, and I Miyoshi
September 1991, The Pediatric infectious disease journal,
Copied contents to your clipboard!